Financials Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. 23:00:00 16/05/2024 BST 5-day change 1st Jan Change
191,500 KRW -0.78% Intraday chart for Celltrion, Inc. -0.73% -4.96%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 24,175,552 48,989,351 27,592,583 23,000,359 27,970,378 39,491,115 - -
Enterprise Value (EV) 2 24,047 49,090 27,117 23,236 27,970 40,035 39,230 38,154
P/E ratio 77.7 x 94.4 x 47.2 x 41.6 x 53.7 x 74.2 x 36.1 x 25.1 x
Yield - - 0.38% - 0.25% 0.23% 0.24% 0.29%
Capitalization / Revenue 21.4 x 26.5 x 14.6 x 10.1 x 12.9 x 11.2 x 9.4 x 7.88 x
EV / Revenue 21.3 x 26.5 x 14.3 x 10.2 x 12.9 x 11.3 x 9.34 x 7.61 x
EV / EBITDA 44.8 x 55.1 x 27.9 x 26.6 x 31.2 x 40.6 x 23.8 x 17 x
EV / FCF 63.3 x 186 x 46 x -211 x 85.5 x 54.5 x 37.9 x 30.4 x
FCF Yield 1.58% 0.54% 2.17% -0.47% 1.17% 1.83% 2.64% 3.29%
Price to Book 8.27 x 14.4 x 6.87 x 5.34 x 2.46 x 2.38 x 2.42 x 2.09 x
Nbr of stocks (in thousands) 144,521 144,757 144,931 143,304 138,811 206,220 - -
Reference price 3 167,280 338,424 190,385 160,500 201,500 191,500 191,500 191,500
Announcement Date 19/02/20 22/02/21 16/02/22 03/03/23 29/02/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,128 1,849 1,891 2,284 2,176 3,534 4,201 5,013
EBITDA 1 537.3 891.4 972.1 873.6 897.2 985.2 1,647 2,248
EBIT 1 378.1 712.1 753.9 647.2 651.5 700.1 1,523 2,180
Operating Margin 33.5% 38.51% 39.87% 28.34% 29.93% 19.81% 36.25% 43.5%
Earnings before Tax (EBT) 1 378.6 650.7 746.9 626.2 671.1 704.9 1,523 2,080
Net income 1 297.6 511.3 575.1 533.2 535.6 552 1,126 1,616
Net margin 26.37% 27.65% 30.42% 23.34% 24.61% 15.62% 26.8% 32.24%
EPS 2 2,153 3,586 4,031 3,855 3,753 2,580 5,300 7,619
Free Cash Flow 3 379,716 263,739 589,594 -110,305 327,112 734,000 1,034,400 1,255,500
FCF margin 33,649.04% 14,262.95% 31,181.9% -4,829.54% 15,029.76% 20,768.55% 24,625.27% 25,046.74%
FCF Conversion (EBITDA) 70,673.9% 29,586.45% 60,648.72% - 36,460.8% 74,504.17% 62,789.7% 55,861.58%
FCF Conversion (Net income) 127,593.57% 51,582.76% 102,521.45% - 61,068.54% 132,971.01% 91,883.14% 77,684.96%
Dividend per Share 2 - - 721.2 - 500.0 431.0 468.5 562.8
Announcement Date 19/02/20 22/02/21 16/02/22 03/03/23 29/02/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 401 601.1 550.6 596.1 645.6 510.6 597.5 524 672.3 382.6 737 792.7 921.3 1,050 975.3
EBITDA 1 - - - - - - - - - - 147 200 - - 445
EBIT 1 164 219 142.3 199 213.8 100.6 182.4 183 267.6 18.42 15.44 94.57 231.8 341.2 320.8
Operating Margin 40.9% 36.43% 25.84% 33.38% 33.11% 19.71% 30.52% 34.92% 39.81% 4.82% 2.09% 11.93% 25.15% 32.51% 32.89%
Earnings before Tax (EBT) 187.6 145.2 - 226.8 217.3 48.49 208.2 189.7 282.9 - - - - - -
Net income 1 135.5 120.5 118.5 183.4 166.7 64.53 166.9 147.5 221.8 1.054 22.44 87.17 219.8 277.7 296
Net margin 33.79% 20.04% 21.53% 30.77% 25.82% 12.64% 27.93% 28.15% 33% 0.28% 3.04% 11% 23.86% 26.46% 30.35%
EPS - - - - 1,162 470.0 1,155 1,034 1,561 - - 494.3 954.4 1,330 -
Dividend per Share 2 - - - - - - - - - 500.0 - - - 200.0 -
Announcement Date 10/11/21 16/02/22 12/05/22 05/08/22 09/11/22 03/03/23 08/05/23 14/08/23 07/11/23 29/02/24 09/05/24 - - - -
1KRW in Billions2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 100 - 236 - 544 - -
Net Cash position 1 128 - 476 - - - 261 1,337
Leverage (Debt/EBITDA) - 0.1126 x - 0.2696 x - 0.5522 x - -
Free Cash Flow 2 379,716 263,739 589,594 -110,305 327,112 734,000 1,034,400 1,255,500
ROE (net income / shareholders' equity) 11.2% 16.7% 16.5% 12.9% 5.07% 3.18% 7.87% 8.42%
ROA (Net income/ Total Assets) 8.02% 11.6% 10.7% 9.22% 4.31% 2.97% 5.48% 7.14%
Assets 1 3,713 4,402 5,372 5,783 12,421 18,607 20,531 22,635
Book Value Per Share 3 20,218 23,501 27,732 30,040 81,950 80,382 79,262 91,658
Cash Flow per Share 3 3,430 2,460 6,417 6.250 3,764 3,945 7,788 10,103
Capex 1 94.3 87 63.4 111 210 128 183 191
Capex / Sales 8.35% 4.71% 3.35% 4.87% 9.65% 3.62% 4.35% 3.8%
Announcement Date 19/02/20 22/02/21 16/02/22 03/03/23 29/02/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
191,500 KRW
Average target price
232,471 KRW
Spread / Average Target
+21.39%
Consensus
  1. Stock Market
  2. Equities
  3. A068270 Stock
  4. Financials Celltrion, Inc.